Clarification to the www.qtdrugs.org updated lists

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 5, 2009, Pages 423-424

  Romero, Klaus ^a   Woosley, Raymond L ^a  

^a CRITICAL PATH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DRUG CONTRAINDICATION; DRUG FORMULARY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; INTERNET; LETTER; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; TORSADE DES POINTES; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; FACTUAL DATABASE; NOTE;

DATABASES, FACTUAL; ELECTROCARDIOGRAPHY; HUMANS; INTERNET; TORSADES DE POINTES;

EID: 67649403730     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1727     Document Type: Letter

References (14)

1. Nemerott CB. Overview of the safety of citalopram. Psychopharmacol Bull 2003; 37(1): 96-121.
2. Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 277-295.
3. Tarabar AF, Hoffman RS, Nelson LS. Citalopram overdose: Late presentation of TdP (TdP) with cardiac arrest. J Med Toxicol 2008; 4(2): 101-105.
4. Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of Citalopram and the newer antidepressants after overdose. J Toxicol/Clin Toxicol 2004; 42: 67-71.
5. Nelson LS, Erdman AR, Booze LL, et al. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2007; 45: 315-332.
6. Catalano G, Catalano MC, Epstein MA, Tsambiras PE. QTc interval prolongation associated with Citalopram overdose: A case report and literature review. Clin Neuropharmacol 2001; 24(3): 158-162.
7. Isbister GK, Friberg LE, Stokes B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med. 2007; 50(5): 593-600.
8. Rothenhäusler HB, Hoberl C, Ehrentrout S, Kapfhammer HP, Weber MM. Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: Successful therapy with a temporary pacemaker. Pharmacopsychiatry. 2000; 33(4): 150-152.
9. Blaschke D, Parwani AS, Huemer M, Torsade de pointes during combined treatment with risperidone and citalopram. Pharmacopsychiatry. 2007; 40(6): 294-295.
10. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004; 42(3): 277-285.
11. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965; 58: 295-300.
12. Shakir SA, Layton D. Causal association in pharmacovigilance and pahrmacoepidemiology: Thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf 2002; 25(6): 467-471.
13. Perrio M, Voss S, Shakir SA. Application of the Bradford Hill criteria to assess the causality of cisapride-induced arrhythmia. Drug Safety 2007; 30(4): 333-346.
14. Woosley RL. Discovering adverse reactions: Why does it take so long? Clin Pharmacol Ther. 2004; 76(4): 287-289.